Profile
James Mond served as the Chief Medical Officer at Phase III Medical, Inc. before becoming the Executive VP, Chief Scientific & Medical Officer at ADMA Biologics, Inc. where he worked from 2012 to 2021.
Prior to that, he was the Chief Scientific Officer at Biosynexus, Inc. from 1999 to 2011.
He also worked as a Professor at the Uniformed Services University of the Health Sciences.
Dr. Mond holds a doctorate degree from the New York University School of Medicine.
Former positions of James Mond
| Companies | Position | End |
|---|---|---|
| ADMA BIOLOGICS, INC. | Chief Tech/Sci/R&D Officer | 2021-06-07 |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Chief Tech/Sci/R&D Officer | 2011-05-31 |
| Phase III Medical, Inc. | Chief Tech/Sci/R&D Officer | - |
| Uniformed Services University of the Health Sciences | Corporate Officer/Principal | - |
Training of James Mond
| New York University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ADMA BIOLOGICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Biosynexus, Inc.
Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Health Technology |
| Phase III Medical, Inc. | Finance |
- Stock Market
- Insiders
- James Mond
